Hyun-Soo Kim
Vermogen: 43 M $ op 31-08-2026
Vermogen: 43 M $ op 31-08-2026
Hyun-Soo Kim currently works at Pharmicell Co., Ltd., as Chairman & Chief Executive Officer from 2009.
Mr. Kim also formerly worked at FCB Twelve Co., Ltd., as Co-CEO, Director, Head-Research & Development from 2009 to 2011 and FCB-Pharmicell Co., Ltd., as Chief Executive Officer & Director from 2010 to 2011.
Mr. Kim received his undergraduate degree from Yonsei University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARMICELL CO., LTD 10,93% | 08-10-2026 | 6.559.547 ( 10,93% ) | 53 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMICELL CO., LTD. | Algemeen Directeur | 19-08-2009 |
| Bedrijven | Functie | Einde |
|---|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | President | 06-10-2011 |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | President | 27-06-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | Consumer Non-Durables |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | Commercial Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmicell Co., Ltd.
Pharmicell Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops stem cell based pharmaceuticals and technologies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau